Tifluadom, a κ-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist
- 12 December 1986
- journal article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 72 (2), 211-214
- https://doi.org/10.1016/0304-3940(86)90082-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiatesBrain Research, 1985
- Further evidence that substance P partly mediates the action of cholecystokinin octapeptide (CCK-8) on the guinea pig ileum but not gall bladder: Studies with a substance P antagonistNeuroscience Letters, 1984
- The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviorsEuropean Journal of Pharmacology, 1983
- Reverse stereoselectivity of opiate and benzodiazepine receptors for the opioid benzodiazepine tifluadomEuropean Journal of Pharmacology, 1983
- An opioid benzodiazepineNature, 1982